Suppr超能文献

溴酸盐诱导肾细胞中 p21 的 DNA 甲基化和组蛋白乙酰化改变。

Bromate-induced Changes in p21 DNA Methylation and Histone Acetylation in Renal Cells.

机构信息

Department of Pharmaceutical and Biomedical Sciences.

Interdisciplinary Toxicology Program.

出版信息

Toxicol Sci. 2019 Apr 1;168(2):460-473. doi: 10.1093/toxsci/kfz016.

Abstract

Bromate (BrO3-) is a water disinfection byproduct (DBP) previously shown to induce nephrotoxicity in vitro and in vivo. We recently showed that inhibitors of DNA methyltransferase 5-aza-2'-deoxycytidine (5-Aza) and histone deacetylase trichostatin A (TSA) increased BrO3- nephrotoxicity whereas altering the expression of the cyclin-dependent kinase inhibitor p21. Human embryonic kidney cells (HEK293) and normal rat kidney (NRK) cells were sub-chronically exposed to BrO3- or epigenetic inhibitors for 18 days, followed by 9 days of withdrawal. DNA methylation was studied using a modification of bisulfite amplicon sequencing called targeted gene bisulfite sequencing. Basal promoter methylation in the human p21 promoter region was substantially lower than that of the rat DNA. Furthermore, 5-Aza decreased DNA methylation in HEK293 cells at the sis-inducible element at 3 distinct CpG sites located at 691, 855, and 895 bp upstream of transcription start site (TSS). 5-Aza also decreased methylation at the rat p21 promoter about 250 bp upstream of the p21 TSS. In contrast, sub-chronic BrO3- exposure failed to alter methylation in human or rat renal cells. BrO3- exposure altered histone acetylation in NRK cells at the p21 TSS, but not in HEK293 cells. Interestingly, changes in DNA methylation induced by 5-Aza persisted after its removal; however, TSA- and BrO3--induced histone hyperacetylation returned to basal levels after 3 days of withdrawal. These data demonstrate novel sites within the p21 gene that are epigenetically regulated and further show that significant differences exist in the epigenetic landscape between rat and human p21, especially with regards to toxicant-induced changes in histone acetylation.

摘要

溴酸盐(BrO3-)是一种水消毒副产物(DBP),先前已被证明在体外和体内具有肾毒性。我们最近发现,DNA 甲基转移酶 5-氮杂-2'-脱氧胞苷(5-Aza)和组蛋白去乙酰化酶曲古抑菌素 A(TSA)抑制剂会增加 BrO3-的肾毒性,而改变细胞周期蛋白依赖性激酶抑制剂 p21 的表达。人胚肾细胞(HEK293)和正常大鼠肾(NRK)细胞被亚慢性暴露于 BrO3-或表观遗传抑制剂 18 天,然后撤药 9 天。使用称为靶向基因亚硫酸氢盐测序的亚硫酸氢盐扩增子测序的修饰来研究 DNA 甲基化。人 p21 启动子区域的基础启动子甲基化明显低于大鼠 DNA。此外,5-Aza 在 3 个不同的 CpG 位点(位于转录起始位点(TSS)上游 691、855 和 895 bp 处)处降低了 HEK293 细胞中 sis 诱导元件的 DNA 甲基化。5-Aza 还降低了大鼠 p21 启动子中大约 250 bp 上游的甲基化。相比之下,亚慢性 BrO3-暴露未能改变人或大鼠肾细胞中的甲基化。BrO3-暴露改变了 NRK 细胞中 p21 TSS 处的组蛋白乙酰化,但未改变 HEK293 细胞中的组蛋白乙酰化。有趣的是,5-Aza 诱导的 DNA 甲基化变化在其去除后仍然存在;然而,TSA-和 BrO3-诱导的组蛋白过度乙酰化在撤药 3 天后恢复到基础水平。这些数据表明 p21 基因内存在新的表观遗传调控位点,并且进一步表明大鼠和人 p21 之间的表观遗传景观存在显著差异,特别是在组蛋白乙酰化方面与毒物诱导的变化有关。

相似文献

4
Nephrotoxicity of epigenetic inhibitors used for the treatment of cancer.用于癌症治疗的表观遗传抑制剂的肾毒性。
Chem Biol Interact. 2016 Oct 25;258:21-9. doi: 10.1016/j.cbi.2016.08.010. Epub 2016 Aug 16.

本文引用的文献

2
Nephrotoxicity of epigenetic inhibitors used for the treatment of cancer.用于癌症治疗的表观遗传抑制剂的肾毒性。
Chem Biol Interact. 2016 Oct 25;258:21-9. doi: 10.1016/j.cbi.2016.08.010. Epub 2016 Aug 16.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验